PNPLA3 and metabolic dysfunction-associated steatotic liver disease: Finally, we assessed whether expression of PNPLA3 is altered in patients with NAFLD by assessing PNPLA3 gene expression in liver biopsies obtained from nondiabetic obese subjects with NAFLD (Supporting Table 3).